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Abstract
Background: Structural myocardial abnormalities have been extensively documented in hypothyroidism. 
Experimental studies in animal models have also shown involvement of thyroid hormones in gene expression of 
myocardial collagen. This study was planned to investigate the ability of ultrasonic tissue characterization, as evaluated 
by integrated backscatter (IBS), to early identify myocardial involvement in thyroid dysfunction.
Patients and Methods: We studied 15 patients with hyperthyroidism (HYPER), 8 patients with hypothyroidism (HYPO), 
14 patients with subclinical hypothyroidism (SCH) and 19 normal (N) subjects, who had normal LV systolic function. 
After treatment, 10 HYPER, 6 HYPO, and 8 SCH patients were reevaluated. IBS images were obtained and analyzed in 
parasternal short axis (papillary muscle level) view, at left ventricular (LV) posterior wall. The following IBS variables were 
analyzed: 1) the corrected coefficient (CC) of IBS, obtained by dividing IBS intensity by IBS intensity measured in a 
rubber phantom, using the same equipment adjustments, at the same depth; 2) cardiac cyclic variation (CV) of IBS - 
peak-to-peak difference between maximal and minimal values of IBS during cardiac cycle; 3) cardiac cyclic variation 
index (CVI) of IBS - percentual relationship between the cyclic variation (CV) and the mean value of IBS intensity.
Results: CC of IBS was significantly larger (p < 0.05) in HYPER (1.57 ± 0.6) and HYPO (1.53 ± 0.3) as compared to SCH 
(1.32 ± 0.3) or N (1.15 ± 0.27). The CV (dB) (HYPO: 7.5 ± 2.4; SCH: 8.2 ± 3.1; HYPER: 8.2 ± 2.0) and the CVI (HYPO: 35.6 ± 
19.7%; SCH: 34.7 ± 17.5%; HYPER: 37.8 ± 11.6%) were not significantly different in patients with thyroid dysfunction as 
compared to N (7.0 ± 2.0 and 44.5 ± 15.1%).
Conclusions: CC of IBS was able to differentiate cardiac involvement in patients with overt HYPO and HYPER who had 
normal LV systolic function. These early myocardial structural abnormalities were partially reversed by drug therapy in 
HYPER group. On the other hand, although mean IBS intensity tended to be slightly larger in patients with SCH as 
compared to N, this difference was not statistical significant.
Introduction
Information regarding myocardial ultra-structure and
composition can be provided by ultrasonic tissue charac-
terization, a non-invasive technique which is capable of
detecting and quantifying acoustic properties of myocar-
dial tissue [1]. The intensity of the IBS is related to physi-
cal properties of myocardium and is influenced by tissue
components (collagen, water, fat) and spatial distribution
of these components [1,2]. In addition, intensity of the
IBS also depends on ultra-sound system settings and on
ultrasound attenuation [3,4]. A number of investigations
have shown that morphologic changes in myocardium
occurring in various diseases are associated with
increased integrated backscatter (IBS) [5-10]. During car-
diac contraction and relaxation, a cardiac cycle-depen-
dent variation of myocardial IBS can be documented. The
magnitude of cyclic variation of IBS is an additional
acoustic parameter, which is more strictly correlated with
myocardial contractile function [11,12] and independent
of ultrasound system settings.
It has been consensually recognized that thyroid dys-
function is associated to remarkable changes in cardiac
structure and function [13,14]. Thyroid hormones effects
on the heart are exerted both by direct influence at cellu-
lar level, involving nuclear and extranuclear mechanisms,
* Correspondence: bcmaciel@fmrp.usp.br
1 Division of Cardiology, Department of Internal Medicine, University Hospital, 
Medical School of Ribeirão Preto, University of São Paulo, Brazil
Full list of author information is available at the end of the articleRomano et al. Cardiovascular Ultrasound 2010, 8:15
http://www.cardiovascularultrasound.com/content/8/1/15
Page 2 of 7
and by indirect interactions with the renin-angiotensin-
aldosterone system, sympathetic nervous system, natri-
uretic peptides and erythropoietin secretion [13,14].
There is experimental evidence showing a regulatory
involvement of thyroid hormones on interstitial protein
gene expression, modulating production of collagen type
I, a main component of the heart matrix, which plays an
important role in maintaining the integrity of myocardial
function [15]. Despite of that, there are very few studies
[16-19] noninvasively analyzing the ultrastructural char-
acteristics of heart muscle using ultrasound. Therefore,
this study was designed to investigate the ability of ultra-
sonic tissue characterization to identify early myocar-
dium involvement in patients with thyroid dysfunction,
including overt hypothyroidism and hyperthyroidism, as
well as subclinical hypothyroidism, before and after drug
therapy.
Methods
Study group
Fifty-six subjects, of both sexes, were evaluated in this
study, including 19 healthy volunteers (16 male), mean
age 43 ± 8.4 years (mean ± SD) (Controls) and 37
patients with thyroid dysfunction divided in the following
groups: Hyperthyroidism (HYPER), including 15 female
patients, mean age 30.3 ± 7.9 years; Hypothyroidism
(HYPO), consisting of 8 patients (5 female), mean age 40
± 7.8 years, and Subclinical Hypothyroidism (SCH),
comprising 14 female patients, mean age 41.2 ± 8.0 years.
Clinical diagnosis of newly untreated thyroid dysfunction
was confirmed by immunoassay determination of hor-
mone levels (TSH, FT4 and FT3). None of these patients
had any clinical, electrocardiographic or echocardio-
graphic evidence of cardiovascular disease. At least six
months after clinical and metabolic control by drug ther-
apy, 10 HYPER, 6 HYPO, and 8 SCH patients were
reevaluated. Laboratory reference values for thyroid hor-
mones were: TSH - 0.5 to 4.5 μU/ml; FT4 - 07 to 1.7 ng/dl
and FT3 - 1.5 to 4.1 pg/ml. Patients presenting overt and
subclinical hypothyroidism were treated with graded sub-
stitutive doses of levothyroxine, while patients with overt
hyperthyroidism received methimazole. The protocol
was approved by the institutional ethics committee. All
subjects who were included in this investigation provided
written informed consent.
Protocol
M-mode and 2D echocardiograms and Doppler analysis
were performed in all subjects using a commercially
available ultrasound system (Philips Sonos 5500;
Andover, Massachussets) with a S4 (2-4 MHz) trans-
ducer. Two dimensional images were obtained in
parasternal long-axis and short axis views and in apical
four and two chamber views. M-mode measurements of
aorta, left atrium, right ventricle, left ventricle diastolic
and systolic dimensions in addition to diastolic dimen-
sion of the interventricular septum and the left ventricu-
lar posterior wall were obtained in all subjects. Global left
ventricular systolic function was evaluated by quantifying
ejection fraction using Simpson's method on apical two
and four chamber views.
Two dimensional ultrasonic backscatter images of left
ventricle were obtained using an on-line acoustic densi-
tometry package incorporated in the same imaging sys-
tem from paraesternal short axis view at papillary muscle
level. This ultrasound system provided two-dimensional
echocardiographic images in which the gray level is rep-
resented proportional to the integrated backscatter.
Images were captured on a cine loop (2 seconds at 30
frames/sec), displayed and stored on optical disk. Back-
scatter was measured in decibels, ranging from 10 to 40
dB, from an elliptical region of interest, 11 × 11 to 31 × 31
pixels. The largest possible region of interest was placed
at the center of the posterior wall myocardial segment,
taking care to avoid bright specular echoes from endocar-
dium or epicardium and to keep the region of interest
within the myocardial borders during cardiac cycle. For
each view evaluated, a cine-loop from a rubber phantom,
using the same system settings, was also acquired (Figure
1). Each segment was evaluated in triplicate and the mean
values of each variable were used in the statistical analy-
sis.
For each myocardial segment, the acoustic densitome-
try package provided the following variables: a mean inte-
grated backscatter and the magnitude of cyclic variation
of IBS. Integrated backscatter was calibrated for system
settings and tissue attenuation by dividing mean intensity
of IBS, at posterior left ventricular segment, by IBS mean
intensity measured in the rubber phantom image,
acquired using the same system settings at the same
depth as the LV segment. This variable was the corrected
coefficient (CC) of IBS. Magnitude of cyclic variation
(CV) of IBS was obtained as the difference between the
average peak and average nadir values of IBS. We also cal-
culated the cardiac cyclic variation index (CVI) of IBS, as
measured by the percentual relationship between CV and
the mean value of IBS intensity.
Statistical analysis
All data are presented as mean ± standard deviation.
Non-parametric Kruskal-Wallis test with Dunn's multiple
comparisons test, when applicable, was used to compare
continuous variables. Wilcoxon non-parametric test was
used to compare patients with thyroid dysfunction before
and after treatment. Simple linear regression analysis was
used for evaluation of relationship between hormone lev-
els and IBS variables. A p value < 0.05 was considered as
statistically significant.Romano et al. Cardiovascular Ultrasound 2010, 8:15
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Results
Clinical and hormonal data of patients with thyroid dys-
function and controls are shown in Table 1. Subjects with
hyperthyroidism presented a significantly lower (p < 0.01)
mean age (30.3 ± 7.9 years; mean ± SD) as compared to
control group (43 ± 8.4 years), patients with overt (40.0 ±
7.8 years) or subclinical hypothyroidism (41.2 ± 8.0
years). Predominance of female patients was observed in
thyroid dysfunction groups while control group was com-
posed by a majority of male subjects. By selection,
patients presenting hyperthyroidism had suppressed TSH
levels and increase FT4 and FT3 values while patients with
overt hypothyroidism showed very high levels of TSH
and reduced values of FT4; on the other hand, a slight
increase of TSH and FT4 levels in the normal reference
range were observed in patients with subclinical hypothy-
roidism.
Table 1: Clinical, hormonal and echocardiographic variables (mean ± SD) in patients with thyroid dysfunction and controls
Hyperthyroidism
(n = 15)
Hypothyroidism
(n = 8)
Subclinical 
Hypothyroidism
(n = 14)
Controls
(n = 19)
Age (yrs) 30.3 ± 7.9a 40 ± 7.8 41.2 ± 8.0 43 ± 8.4
Sex (F:M) 15:0 5:3 14:0 3:16
BSA (m2) 1.6 ± 0.2 1.8 ± 0.2 1.6 ± 0.1 1.8 ± 0.1
HR (beats/min) 90.6 ± 19.3 66.3 ± 10.5 77.5 ± 13.1 72.8 ± 15.4
EF (%) 70.2 ± 5.4 69.4 ± 5.4 70.1 ± 6.6 66.2 ± 7.3
LVMI (g/m2) 76.5 ± 14.7 85.9 ± 17.0 67.8 ± 9.0 89.8 ± 20.2
LVd (cm) 4.9 ± 0.2 4.8 ± 0.3 4.7 ± 0.3 4.9 ± 4.6
TSH (mU/L) 0.01 ± 0.009 156.5 ± 97.7 12.6 ± 7.8 -
FT4(ng/dl) 4.24 ± 1.6 0.2 ± 0.07 0.9 ± 0.2 -
FT3(pg/ml) 11.5 ± 8.0 - - -
yrs = years; F = female; M = male; BSA = body surface area; HR = heart rate; EF = ejection fraction; LVd = left ventricular diastolic dimension; 
LVMI = left ventricular mass index; LVd = left ventricle diastolic dimension; TSH = thyroid stimulator hormone; FT4 = free T4; FT3 = free T3; a:p 
< 0.01 vs hypothyroidism, subclinical hypothyroidism and controls.
Figure 1 IBS curves from posterior wall of the left ventricle (A) and from a rubber phantom, maintaining sample (arrows) in the same depth 
and same system settings (B).
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On baseline Doppler echocardiography study (Table 1),
left ventricular diastolic dimension, left ventricular mass
index and ejection fraction had comparable values for
normal subjects and patients with thyroid dysfunction.
The corrected coefficient of IBS was significantly
higher among patients with overt hyperthyroidism and
hypothyroidism (Figure 2) as compared to normal sub-
jects. Even though there was a clear tendency for higher
values of this myocardial texture index in patients with
subclinical hypothyroidism, statistical significance could
not be demonstrated (Table 2, Figure 3).
When magnitude of cyclic variation (CV) of the inte-
grated backscatter and cardiac cyclic variation index
(CVI) of IBS were compared in normal subjects and dif-
ferent groups of thyroid dysfunction patients, these IBS
indices were not consistently different between groups
(Table 2).
Figure 2 IBS curves of patients with subclinical hypothyroidism (A); hypothyroidism (B) and hyperthyroidism (C).
A
B
C
Figure 3 Integrated backscatter (IBS) variables (mean ± SD) in pa-
tients with thyroid dysfunction and controls. CC of IBS = corrected 
coefficient of IBS; Hyper = hyperthyroidism; Hypo = hypothyroidism; 
SCH = subclinical hypothyroidism.Romano et al. Cardiovascular Ultrasound 2010, 8:15
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Considering that the corrected coefficient of IBS in the
control group have shown a normal distribution, we com-
pared individual values for this variable in the thyroid
dysfunction patients in the range of mean ± 2 SD. It was
observed that 4 out 15 patients with hyperthyroidism
(27%) and 1 out 14 patients (7.1%) of patients with sub-
clinical hypothyroidism had corrected coefficients of IBS
higher than the upper normal limit while almost all
patients with overt hypothyroidism had IBS values close
to this upper limit.
Table 3 shows clinical, echocardiographic and hor-
monal data for thyroid dysfunction patients who were
evaluate before and after clinical treatment. Besides sig-
nificant changes after treatment showing return of thy-
roid hormone levels within normal range, a significant
reduction of left ventricular diastolic dimension was doc-
umented after clinical control of disease.
Mean values of the corrected coefficient of IBS tended
to reduce in patients with overt hyperthyroidism and
hypothyroidism after treatment, although this reduction
was not statistically significant. Despite a clear tendency
of increasing values of the absolute MCV of the inte-
grated backscatter and cardiac cyclic variation index
(CVI) of IBS after drug therapy were documented in all
groups of thyroid dysfunction, statistical significance (p <
0.05) was reached only by the magnitude of cyclic varia-
tion of IBS for patients with overt hypothyroidism (Table
4). In addition, most of those patients who were evaluated
after drug therapy presented a marked reduction of the
corrected coefficient of IBS.
Discussion
The results of the present investigation have shown that
calibrated myocardial integrated backscatter, as mea-
sured by the corrected coefficient of IBS, was able to early
demonstrate myocardial texture abnormality in patients
with overt hyperthyroidism and hypothyroidism who had
normal left ventricular systolic function, but not in
patients with subclinical hypothyroidism. In addition,
myocardial cyclic variation of IBS and cyclic variation
index were not able to differentiate thyroid dysfunction
patients from normal subjects. On the other hand, clini-
cal and metabolic control of thyroid dysfunction tended
to reduce IBS intensity and to increase cyclic variation of
IBS in hyperthyroid and hypothyroid patients.
Table 3: Clinical, Hormonal and Echocardiographic variables (mean ± SD) in patients with Thyroid Dysfunction before and 
after treatment
Hyperthyroidism
(n = 10)
Hypothyroidism
(n = 6)
Subclinical Hypothyroidism
(n = 8)
Baseline Treatment Baseline Treatment Baseline Treatment
HR (min-1) 90.7 ± 23.5 80 ± 16.4 67.3 ± 11.1 69.7 ± 13.8 78.8 ± 14.3 78.3 ± 10.7
EF (%) 70.4 ± 5.6 71.7 ± 5.1 70.7 ± 4.7 71.0 ± 5.2 71.2 ± 5.4 72 ± 4.4
LVMI (g/m2) 72.2 ± 11.1 68.0 ± 11.5 82.0 ± 15.7 80.7 ± 16.0 70.8 ± 9.7 69.2 ± 10.2
LVd (cm) 4.9 ± 0.3 4.7 ± 0.3 a 4.9 ± 0.2 4.9 ± 0.2 4.8 ± 0.3 4.8 ± 0.3
TSH (mU/L) 0.009 ± 0.01 2.1 ± 1.4 b 141.2 ± 96.9 1.7 ± 1.5 a 10.6 ± 7.1 2.4 ± 1.3a
FT4 (ng/dl) 4.3 ± 1.6 1.2 ± 0.2 b 0.2 ± 0.08 1.53 ± 0.2a 1.0 ± 0.2 1.4 ± 0.3 a
FT3 (pg/ml) 13.5 ± 9.2 3.1 ± 0.9 - - - -
a = p < 0.05; b = p < 0.005 vs baseline
HR = heart rate; EF = ejection fraction; LVMI = left ventricular mass index; LVd = left ventricular diastolic dimension; TSH = thyroid stimulator 
hormone; FT4 = free T4; FT3 = free T3
Table 2: Integrated backscatter (IBS) variables (mean ± SD) in patients with Thyroid Dysfunction and Controls
Hyperthyroidism (n = 
15)
Hypothyroidism (n = 
8)
Subclinical 
Hypothyroidism (n = 
14)
Controls
(n = 19)
CC of IBS 1.57 ± 0.6 a 1.53 ± 0.3 a 1.32 ± 0.3 1.2 ± 0.3
CV (dB) 8.2 ± 2.0 7.5 ± 2.4 8.2 ± 3.1 7 ± 2.0
CVI (%) 37.8 ± 11.6 35.6 ± 19.7 34.7 ± 17.5 44.5 ± 15.1
a = p < 0.05 vs controls; CC of IBS = correct coefficient of IBS; CV = absolute cyclic variation of IBS; CVI = percentual relationship between CV 
and mean value of IBSRomano et al. Cardiovascular Ultrasound 2010, 8:15
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The increased myocardial echoreflectivity we docu-
mented in patients with overt hypothyroidism has been
previously reported [17]. Taking into account the recog-
nized correlation between ultrasound backscatter inten-
sity and histologically quantified myocardial fibrosis [20],
this finding is consistent with experimental data suggest-
ing involvement of thyroid hormones in regulating myo-
cardial fibrosis by modulating collagen synthesis [15].
On the other hand, to the best of our knowledge, the
increased myocardial texture observed in patients pre-
senting overt hyperthyroidism has not been previously
described. A previous investigation [17] comparing
patients with hyperthyroidism to normal subjects did not
find significant changes in cardiac echoreflectivity. Di
Bello et al [21], have already demonstrated an increase in
CV of IBS in subclinical hyperthyroidism without any dif-
ferences in IBS intensity versus control group. In con-
trast, our data suggest that at least some patients with
hyperthyroidism have a degree of myocardial fibrosis,
reflected by increased CC of IBS, which tended to reverse
after treatment. Considering that: 1) myocardial fibrosis
depends on a complex relationship between stimulatory
(including: angiotensin II, endothelin I, catecholamines
and aldosterone) and inhibitory factors acting on the col-
lagen production [22]; 2) renin-angiotensin-aldosterone
system is activacted in patients with hyperthyroidism
[13,14]; 3) thyroid hormones may influence the respon-
siveness and sensitivity of cardiac tissue to normal sym-
pathetic stimulation [13]; it is reasonable to admit that
these mechanisms could mediate the increased myocar-
dial texture observed in these patients.
Our results regarding myocardial cyclic variation of IBS
and cyclic variation index are in disagreement with previ-
ous publications [16,18,19,21] which have shown signifi-
cant lower cyclic variation in patients with subclinical
hypothyroidism while our data were not able to differen-
tiate thyroid dysfunction patients from normal subjects.
Those observations have been considered to indicate an
early myocardial dysfunction in patients presenting sub-
clinical hypothyroidism.
To conciliate our results with previous publications, we
should consider a number of factors. Certainly, a hetero-
geneous composition of the patient population, depend-
ing on different disease duration, baseline hormone
levels, clinical stability and severity of dysfunction, could
contribute to the conflicting results. In addition, the
capability of ultrasonic tissue characterization to detect
early and minor ultra structural changes in myocardial
diseases has not been completely evaluated. In part, this
lack of sensitivity is probably related to the large variabil-
ity of individual values of this variable, documented even
in normal subjects, as previously published [9]. There are
also differences regarding methodology for evaluating
ultrasound tissue characterization. The use of absolute
integrated backscatter to evaluate the acoustic properties
of the myocardium in different clinical conditions has
limited value due to influence of ultrasound system set-
tings and tissue attenuation [3,4] on quantification of IBS
variables. To overcome this limitation, several methods
have been employed to calibrate the absolute value of IBS
by a reference value, derived from ventricular cavity [6],
pericardium [7,8,23,24] or from a rubber phantom [25],
as we utilized in this investigation. Although absolute IBS
values derived from ventricular cavity or pericardium
could be adequate for reducing the influence of the ultra-
sound system settings, they are limited to correct the
effects of ultrasound attenuation.
Despite the marked predominance of female patients in
thyroid dysfunction groups as opposed to preponderance
of male subjects in the control group, it should be men-
tioned that there are not any data showing gender influ-
ence on myocardial tissue characterization variables.
Regression of ultrasonic myocardial texture alterations
have been already documented in clinical scenarios of
hypertrophy regression [26,27]. Although our results
showed a trend toward regression of both IBS indices
(CC IBS and CV) after treatment of patients with overt
hypothyroidism or hyperthyroidism, this was only statis-
tical significant in CV of hypothyroidism patients. This
Table 4: Integrated backscatter (IBS) variables (mean ± SD) in patients with Thyroid Dysfunction before and after 
treatment
Hyperthyroidism
(n = 10)
Hypothyroidism
(n = 6)
Subclinical Hypothyroidism
(n = 8)
Baseline Treatment Baseline Treatment Baseline Treatment
CC of IBS 1.7 ± 0.7 1.3 ± 0.2 b 1.6 ± 0.2 1.4 ± 0.3 1.4 ± 0.2 1.4 ± 0.2
CV (dB) 8.1 ± 2.1 11.1 ± 4.7 8.3 ± 2.0 12.3 ± 2.9 a 8.2 ± 2.7 10.9 ± 4.3
CVI (%) 39.1 ± 11.5 41.5 ± 14.2 41.2 ± 19.6 51.8 ± 16.2 36.1 ± 20.4 52.3 ± 18.4
a = p < 0.05; b = p < 0.08 vs baseline; CC of IBS = correct coefficient of IBS; CV = absolute cyclic variation of IBS; CVI = percentual relationship 
between CV and mean value of IBSRomano et al. Cardiovascular Ultrasound 2010, 8:15
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lack of statistical significance may be related to the lim-
ited numbers of patients evaluated after treatment.
Ultrasonic backscatter can provide important informa-
tion regarding structural and functional alterations in the
myocardium of patients with different types of heart dis-
ease. In this investigation, this technique was able to doc-
ument early myocardial structural abnormalities in
patients with overt hyperthyroidism or hypothyroidism,
and CCIBS was partially reversed by drug therapy in
patients with hyperthyroidism.
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